THE PERFORMANCE OF A RENAL ACTIVITY INDEX IN LUPUS NEPHRITIS IN INDUCTION THERAPY

被引：0
|
作者：
Aljaberi, Najla [1 ]
Hennard, Theresa [1 ]
Mathur, Arjun [1 ]
Brunner, Hermine [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Pediat Rheumatol, Cincinnati, OH 45229 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.2005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0491
引用
收藏
页码：1709 / 1709
页数：1
相关论文
共 50 条
  • [41] Renal arterial resistive index as a prognostic marker in lupus nephritis patients
    Hamid, Samir Kamal Abdul
    Elshazly, Ashraf
    Faisal, Yasser Abd Elmawgood
    M.saleh, Kawsar Abdel Halim
    Aly, Mai Mostafa
    [J]. NEFROLOGIA, 2024, 44 (03): : 373 - 381
  • [42] RENAL RESISTIVE INDEX IN LUPUS NEPHRITIS: A POTENTIAL TOOL FOR CHRONICITY ASSESSMENT
    Tawfik, Mona
    El-Bdrawy, Adel
    El-Said, Ghada
    Barakat, Amira
    Sayed-Ahmed, Nagy
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [43] Mycophenolate as Maintenance Therapy for Lupus Nephritis with Impaired Renal Function
    Rivera, F.
    Illescas, M. L.
    Lopez-Rubio, E.
    Fulladosa, J.
    Poveda, R.
    Baltar, J.
    Fernandez-Juarez, G.
    Ballarin, J.
    Oliet, A.
    Vigil, A.
    Lucas, J.
    Sierra, M.
    Frutos, M. A.
    Garcia-Frias, P.
    Ramosk, C.
    Merida, E.
    Praga, M.
    Segarra, A.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2013, 37 (06) : 509 - 517
  • [44] MYCOPHENOLATE AS MAINTENANCE THERAPY FOR LUPUS NEPHRITIS WITH IMPAIRED RENAL FUNCTION
    Rivera, Francisco
    Segarra, Alfons
    Praga, Manuel
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 182 - 182
  • [45] Urinary Angiotensinogen Predicts Renal Disease Activity in Lupus Nephritis
    Shi, Meng
    Luo, Weihong
    Feng, Xiaodan
    Jin, Lingwei
    Yang, Manqiu
    Wu, Liling
    Yang, Zhichen
    Su, Cailing
    Li, Yajing
    Su, Huanjuan
    Wang, Guobao
    Gao, Wei
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2019, 31 (17) : 1289 - 1301
  • [46] The evolution of lupus activity in patients with end-stage renal disease secondary to lupus nephritis according to the modality of renal replacement therapy.
    Goo, YS
    Kang, EW
    Park, HC
    Park, YB
    Kang, SW
    Choi, KH
    Kim, SIL
    Lee, HY
    Han, DS
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 598A - 598A
  • [47] Therapy of lupus nephritis
    Balzar, E.
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2006, 154 (08) : 826 - 826
  • [48] Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis
    Okamoto, Momoko
    Kitamura, Mineaki
    Sato, Shuntaro
    Fujikawa, Keita
    Horai, Yoshiro
    Matsuoka, Naoki
    Tsuboi, Masahiko
    Nonaka, Fumiaki
    Shimizu, Toshimasa
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Nishino, Tomoya
    Kawakami, Atsushi
    Ichinose, Kunihiro
    [J]. RHEUMATOLOGY, 2021, 60 (05) : 2333 - 2341
  • [49] Geographical variation in the response of lupus nephritis to mycophenolate mofetil induction therapy
    Mohan, S.
    Radhakrishnan, J.
    [J]. CLINICAL NEPHROLOGY, 2011, 75 (03) : 233 - 241
  • [50] Mycophenolate mofetil as induction and maintance therapy of lupus nephritis - our experience
    Raskovic, S.
    Peric-Popadic, A.
    Jovicic, Z.
    Tomic-Spiric, V
    Sojic-Rajcic, J.
    Stefanovic, L.
    Bogic, M.
    [J]. ALLERGY, 2010, 65 : 464 - 464
12345